[1]
“Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson’s Disease Patients”, Colomb Med, vol. 46, no. 3, pp. 117–121, Sep. 2015, doi: 10.25100/cm.v46i3.1553.